These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21657959)

  • 21. Ataxia-telangiectasia mutated and the Mre11-Rad50-NBS1 complex: promising targets for radiosensitization.
    Kuroda S; Urata Y; Fujiwara T
    Acta Med Okayama; 2012; 66(2):83-92. PubMed ID: 22525466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fatal outcome in two girls with hodgkin disease complicating ataxia-telangiectasia (Louis-Bar syndrome) despite favorable response to modified-dose chemotherapy.
    Irsfeld H; Körholz D; Janssen G; Wahn V; Schroten H
    Med Pediatr Oncol; 2000 Jan; 34(1):62-4. PubMed ID: 10611590
    [No Abstract]   [Full Text] [Related]  

  • 23. [Ataxia-telangiectasia: a review].
    Bott L; Thumerelle C; Cuvellier JC; Deschildre A; Vallée L; Sardet A
    Arch Pediatr; 2006 Mar; 13(3):293-8. PubMed ID: 16423518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer. New link in a web of human genes.
    Wang JY
    Nature; 2000 May; 405(6785):404-5. PubMed ID: 10839519
    [No Abstract]   [Full Text] [Related]  

  • 25. Atm and cellular response to DNA damage.
    Lavin MF; Kozlov S; Gueven N; Peng C; Birrell G; Chen P; Scott S
    Adv Exp Med Biol; 2005; 570():457-76. PubMed ID: 18727511
    [No Abstract]   [Full Text] [Related]  

  • 26. ATM and the molecular pathogenesis of ataxia telangiectasia.
    McKinnon PJ
    Annu Rev Pathol; 2012; 7():303-21. PubMed ID: 22035194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exclusion/confirmation of ataxia-telangiectasia via cell-cycle testing.
    Heinrich T; Prowald C; Friedl R; Gottwald B; Kalb R; Neveling K; Herterich S; Hoehn H; Schindler D
    Eur J Pediatr; 2006 Apr; 165(4):250-7. PubMed ID: 16411093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The molecular basis and clinical management of ataxia telangiectasia.
    Spacey SD; Gatti RA; Bebb G
    Can J Neurol Sci; 2000 Aug; 27(3):184-91. PubMed ID: 10975530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Ataxia-telangiectasia mutated gene and breast cancer: gene expression profiles and sequence variants.
    Hall J
    Cancer Lett; 2005 Sep; 227(2):105-14. PubMed ID: 16112413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ATM: from phenotype to functional genomics--and back.
    Shiloh Y
    Ernst Schering Res Found Workshop; 2002; (36):51-70. PubMed ID: 11859564
    [No Abstract]   [Full Text] [Related]  

  • 31. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer.
    Lavin MF
    Nat Rev Mol Cell Biol; 2008 Oct; 9(10):759-69. PubMed ID: 18813293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of adjuvant radiation therapy for breast cancer in women with ataxia-telangiectasia mutations.
    Su Y; Swift M
    JAMA; 2001 Nov; 286(18):2233-4. PubMed ID: 11710885
    [No Abstract]   [Full Text] [Related]  

  • 33. Multiple signaling pathways involving ATM.
    Kastan MB; Lim DS; Kim ST; Xu B; Canman C
    Cold Spring Harb Symp Quant Biol; 2000; 65():521-6. PubMed ID: 12760069
    [No Abstract]   [Full Text] [Related]  

  • 34. Ataxia-telangiectasia mutated (ATM) genetic variant in Italian centenarians.
    Piaceri I; Bagnoli S; Tedde A; Sorbi S; Nacmias B
    Neurol Sci; 2013 Apr; 34(4):573-5. PubMed ID: 22960875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced phosphorylation of transcription factor sp1 in response to herpes simplex virus type 1 infection is dependent on the ataxia telangiectasia-mutated protein.
    Iwahori S; Shirata N; Kawaguchi Y; Weller SK; Sato Y; Kudoh A; Nakayama S; Isomura H; Tsurumi T
    J Virol; 2007 Sep; 81(18):9653-64. PubMed ID: 17609267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional characterization connects individual patient mutations in ataxia telangiectasia mutated (ATM) with dysfunction of specific DNA double-strand break-repair signaling pathways.
    Keimling M; Volcic M; Csernok A; Wieland B; Dörk T; Wiesmüller L
    FASEB J; 2011 Nov; 25(11):3849-60. PubMed ID: 21778326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of DNA repair capacity by ataxia telangiectasia mutated gene polymorphisms among polycyclic aromatic hydrocarbons-exposed workers.
    Wang Y; Cheng J; Li D; Duan H; Yang H; Bin P; Dai Y; Huang C; Liang X; Leng S; Chen W; Zheng Y
    Toxicol Sci; 2011 Nov; 124(1):99-108. PubMed ID: 21873372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ataxia-telangiectasia-mutated-dependent activation of Ku in human fibroblasts exposed to hydrogen peroxide.
    Lee JH; Kim KH; Morio T; Kim H
    Ann N Y Acad Sci; 2006 Dec; 1091():76-82. PubMed ID: 17341604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [From gene to disease; ataxia telangiectasia].
    Broeks A; van 't Veer LJ; Ottenheim C; Hiel JA; Kleijer WJ; Weemaes C
    Ned Tijdschr Geneeskd; 2003 Mar; 147(9):386-9. PubMed ID: 12661456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ATM gene variants in patients with idiopathic perifoveal telangiectasia.
    Barbazetto IA; Room M; Yannuzzi NA; Barile GR; Merriam JE; Bardal AM; Freund KB; Yannuzzi LA; Allikmets R
    Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):3806-11. PubMed ID: 18502988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.